J. A. FRENCH Et Al. , "Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial," 141st Annual Meeting of the American-Neurological-Association , vol.80, Maryland, United States Of America, 2016
FRENCH, J. A. Et Al. 2016. Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial. 141st Annual Meeting of the American-Neurological-Association , (Maryland, United States Of America).
FRENCH, J. A., LAWSON, J. A., Yapici, Z., Polster, T., NABBOUT, R., CURATOLO, P., ... DE VRIES, P. J.(2016). Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial . 141st Annual Meeting of the American-Neurological-Association, Maryland, United States Of America
FRENCH, Jacqueline Et Al. "Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial," 141st Annual Meeting of the American-Neurological-Association, Maryland, United States Of America, 2016
FRENCH, Jacqueline A. Et Al. "Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial." 141st Annual Meeting of the American-Neurological-Association , Maryland, United States Of America, 2016
FRENCH, J. A. Et Al. (2016) . "Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial." 141st Annual Meeting of the American-Neurological-Association , Maryland, United States Of America.
@conferencepaper{conferencepaper, author={Jacqueline A. FRENCH Et Al. }, title={Adjunctive Everolimus Therapy for the Treatment of Refractory Seizures Associated with Tuberous Sclerosis Complex: Results from a Randomized, Placebo-Controlled, Phase 3 Trial}, congress name={141st Annual Meeting of the American-Neurological-Association}, city={Maryland}, country={United States Of America}, year={2016}}